AXA, FR0000120628

Air Liquide consensus stays firmly bullish, shares trade around 166 euros in Paris

Published on 06/23/2026 at 20:34 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Air Liquide carries a clear Buy consensus from major houses, with average 12?month targets near 181 euros while the shares change hands around the mid?160s on Euronext Paris.

AXA, FR0000120628, Illustration mit AI erstellt.
AXA, FR0000120628, Illustration mit AI erstellt.

By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-23, 20:31.

Air Liquide (FR0000120628) sits in the large-cap industrials segment with its shares listed on Euronext Paris under the ticker AI. Recent quote data place the stock around 165.70 euros on the French exchange, according to Euronext-based pricing for AI.PA. MarketScreener quotes for Air Liquide

What analysts are signaling

Across major research aggregators, Air Liquide carries a clear Buy recommendation profile, with 17 of 20 analysts rating the stock Buy, two Hold and just one Sell. The average 12-month price target stands at about 181.10 euros, with published estimates ranging from roughly 152.73 to 200 euros. Investing.com consensus snapshot for Air Liquide

Relative to this consensus range, Air Liquide shares around 165.70 euros trade below the average target, leaving a potential upside of a little more than 9 percent against the 181.10-euro mean estimate cited by Investing.com. The name remains a core member of European industrials, often compared with peers such as Linde in the industrial gases universe.

Recent rating and target moves

Over the past weeks, several houses have refreshed their views on Air Liquide, broadly maintaining a supportive stance. Deutsche Bank most recently reiterated its Buy rating and set a target price of 190 euros, while Goldman Sachs also keeps a Buy recommendation with a 179-euro target, according to analyst round-ups on MarketScreener. MarketScreener analyst actions on Air Liquide

These targets, which cluster in the high-170s to 190-euro area, indicate that large banks still see scope for gains from the current Euronext Paris level. In addition to these updates, summary data from other platforms show the Buy rating consensus intact, underscoring the stock’s status as a preferred play in European industrial gases. Investing.com consensus snapshot for Air Liquide

Go deeper

All news and analysis on the Air Liquide shares

Further background on earnings, strategy and valuation metrics for Air Liquide is available in the dedicated topic overview on ad-hoc-news.de and on the company’s Investor Relations page.

The business behind the stock

Air Liquide generates most of its revenue from supplying industrial gases such as oxygen, nitrogen, hydrogen and specialty mixtures to sectors including healthcare, chemicals, metals and electronics. The group’s Healthcare business also delivers medical gases and home healthcare services to patients, especially in Europe and Spain, where it recently secured a large multi-year respiratory care contract. MarketScreener company news on Air Liquide

Where the shares trade today

The Air Liquide shares (FR0000120628) trade on Euronext Paris under the ticker AI at about 165.70 euros as of 2026-06-18, 16:30, based on recent quote information from exchange-linked data providers tracking AI.PA. eToro quote page for AI.PA

Key data on the Air Liquide shares

  • Company: Air Liquide S.A.
  • ISIN: FR0000120628
  • WKN: 850133
  • Ticker: AI
  • Trading venue: Euronext Paris
  • Price (as of 2026-06-18, 16:30): 165.70 EUR
  • Market cap: around 96 billion EUR (as of mid-June 2026, based on Euronext data and recent share price levels)
  • Sector / industry: Industrials / Industrial Gases
  • Index membership: CAC 40, Euro Stoxx 50
  • Next earnings date: 2026-07-25 (company financial calendar indication)

More on the Air Liquide shares in social media

Disclaimer: This article is for informational purposes only and does not constitute investment advice, an offer, or a solicitation to buy or sell any securities. Investors should conduct their own research or consult a qualified financial adviser before making investment decisions.

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | FR0000120628 | AXA | boerse | 69613055 | bgmi